Amedeo Smart

Free Medical Literature Service

 

Amedeo

Vaccines
  Free Subscription

01.06.2026

1 AIDS
1 BMJ
3 J Infect
1 J Infect Dis
1 J Virol
2 Nat Immunol
1 PLoS Comput Biol
7 PLoS One
29 Vaccine
2 Virology


    AIDS

  1. RYSCAVAGE P, Knable C, Taylor G
    Low measles seroprotection among adults with perinatally acquired HIV.
    AIDS. 2026;40:1041-1043.
    >> Share


    BMJ

  2. DOYON-PLOURDE P, Abrams EM, Pless R, Tunis M, et al
    The story of aluminium containing vaccines is bigger than any one study.
    BMJ. 2026;393:e993389.
    >> Share


    J Infect

  3. WANG X, He L, Li Y, Meng Q, et al
    Pertactin expression in Chinese Bordetella pertussis: A Critical Reappraisal of PRN inclusion in pertussis vaccines.
    J Infect. 2026 May 28:106777. doi: 10.1016/j.jinf.2026.106777.
    >> Share

  4. WEE LE, Ho RWL, Lim JT, Lim SK, et al
    Real-world effectiveness of influenza vaccination amongst children aged under 5 in a tropical setting.
    J Infect. 2026 May 26:106771. doi: 10.1016/j.jinf.2026.106771.
    >> Share

  5. CORRAO G, Sguazzini E, Gori A, Monti E, et al
    All-cause mortality within seven days of COVID-19 vaccination: A matched cohort and self-controlled case series study in Lombardy, Italy.
    J Infect. 2026;93:106769.
    >> Share


    J Infect Dis

  6. RODRIGUEZ-MOLINO P, Rodriguez Galet A, Falces-Romero I, Alcolea S, et al
    Vaccine Response Assessment in Children Using Dried Blood Spots: The DRIVE Study.
    J Infect Dis. 2026 May 26:jiag274. doi: 10.1093.
    >> Share


    J Virol

  7. LOES AN, Tarabi RAL, Li SH, Atkinson RK, et al
    Strain-specific differences in the response to egg-derived versus recombinant protein influenza vaccines.
    J Virol. 2026 May 27:e0031726. doi: 10.1128/jvi.00317.
    >> Share


    Nat Immunol


  8. Fungal glycans boost mRNA-based vaccines.
    Nat Immunol. 2026 May 25. doi: 10.1038/s41590-026-02522.
    >> Share

  9. JENA KK, Qu P, Baracco L, Saghaei S, et al
    A glycan-based adjuvant expands the breadth and duration of protection of mRNA-based vaccines.
    Nat Immunol. 2026 May 22. doi: 10.1038/s41590-026-02517.
    >> Share


    PLoS Comput Biol

  10. KWON J, Li K, Warren JL, Pandya S, et al
    Utilizing virus genomic surveillance to predict vaccine effectiveness.
    PLoS Comput Biol. 2026;22:e1014329.
    >> Share


    PLoS One

  11. RODRIGUEZ-BLANCO N, Vicente-Alcalde N, Orts-Ruiz C, Montero-Navarro S, et al
    Knowledge gaps and positive attitudes toward adult vaccination among nursing students: A Cross-sectional study.
    PLoS One. 2026;21:e0350295.
    >> Share

  12. WARNE DJ, Varghese A, Brewster A, Browning AP, et al
    Bayesian uncertainty quantification to identify population level vaccine hesitancy behaviours.
    PLoS One. 2026;21:e0349499.
    >> Share

  13. WASEEM M, Kamran Z, Ali A
    Advancing poultry health: A meta-analysis of epitope-based and peptide-based vaccines against Avian Pathogenic E. coli with machine learning insights.
    PLoS One. 2026;21:e0349094.
    >> Share

  14. MASUM MHU, Heema HP, Mahdeen AA, Lokman SM, et al
    System immunoinformatics-based design of a multi-epitope vaccine candidate against La Crosse virus.
    PLoS One. 2026;21:e0350287.
    >> Share

  15. FIORE E, Taio G, Morandi N, Mazzotta E, et al
    Lung ultrasonography to assess efficacy of intranasal and parenteral vaccinations for bovine respiratory disease (BRD) in dairy calves.
    PLoS One. 2026;21:e0349953.
    >> Share

  16. ZHAO M, Lei J, Feng Q, Lai S, et al
    Knowledge of HPV and HPV vaccine and its association with vaccination willingness among female undergraduates: A comparative cross-sectional study between healthcare and non-healthcare majors in Chengdu, China.
    PLoS One. 2026;21:e0349013.
    >> Share

  17. WYPLOSZ B, Grenier B, Roche N, Roubille F, et al
    Correction: Pneumococcal vaccination at 65 years and vaccination coverage in at-risk adults: A retrospective population-based study in France.
    PLoS One. 2026;21:e0350226.
    >> Share


    Vaccine

  18. MATHUR V, Schue JL, Fesshaye B, Singh P, et al
    Prevalence and determinants of fully vaccinated status for COVID-19 among pregnant women in Brazil, Ghana, Kenya, and Pakistan.
    Vaccine. 2026 May 29:128708. doi: 10.1016/j.vaccine.2026.128708.
    >> Share

  19. QI X, Smolders C
    From COVAX deliveries to vaccination uptake in LMICs: a monthly panel analysis.
    Vaccine. 2026;86:128763.
    >> Share

  20. SANDERSON K, Butt S, Campbell CNJ, Beck CR, et al
    Interventions to improve pre-school vaccination timeliness: a systematic review.
    Vaccine. 2026;87:128751.
    >> Share

  21. SONG L, He G, Cui Y, Tan R, et al
    Optimized flagellin enhances systemic and mucosal immune responses induced by SARS-CoV-2 virus-like particle vaccines.
    Vaccine. 2026;87:128767.
    >> Share

  22. SUN Y, Keskinocak P, Peak CM, Steimle LN, et al
    Global cessation of bivalent oral polio vaccine (bOPV): A comprehensive review of modeling studies from 2000 to 2025.
    Vaccine. 2026;86:128707.
    >> Share

  23. CASSIMOS DC, Effraimidou E, Irakleidou I, Medic S, et al
    Vaccine-preventable disease outbreaks in schools, part 2: pertussis, meningococcal disease, diphtheria, poliomyelitis, hepatitis A, and rotavirus infection.
    Vaccine. 2026;86:128750.
    >> Share

  24. JUFUKU R, Shinchi H, Murata K, Chan M, et al
    TLR7 ligand-cyclodextrin conjugate is a promising adjuvant for intranasal influenza vaccine.
    Vaccine. 2026;86:128762.
    >> Share

  25. SURAPANENI S, Baxter Z, Abdurrob A, Leonard K, et al
    Using non-primary care clinical settings to increase HPV vaccination uptake: a scoping review.
    Vaccine. 2026;86:128759.
    >> Share

  26. JANECZKO M, Kubinski K, Wawiorka L
    Antifungal vaccine development: where we are, where we are headed.
    Vaccine. 2026;86:128766.
    >> Share

  27. CHOU S, Boman CD
    Increasing prebunking effectiveness to aid disinformation-susceptible publics in overcoming vaccine-related disinformation.
    Vaccine. 2026;86:128749.
    >> Share

  28. SHEN YS, Fang CY, Chan TT, Wu SR, et al
    Propagation and immunological characterization of three enterovirus D68 strains using serum-free HEK293A suspension cell culture.
    Vaccine. 2026;84:128665.
    >> Share

  29. LI W, Li YA, Liu X, Xie H, et al
    Oral immunization with attenuated Salmonella enterica serovar Enteritidis expressing dual-toxin antigen induces protective immunity against avian necrotic enteritis.
    Vaccine. 2026;84:128684.
    >> Share

  30. CARLOCK MA, Ross TM
    Retooling a novel influenza B hemagglutinin to redirect neutralizing antibodies against B/Victoria strains.
    Vaccine. 2026;84:128674.
    >> Share

  31. MYBURGH L, van Loon K, Koetsier J, Hansen Q, et al
    Conjugate vaccine technology enhances responses to influenza virus.
    Vaccine. 2026;86:128728.
    >> Share

  32. LIU R, Fan Y, Xiong S, Lin J, et al
    Drivers of and implementation strategies for influenza vaccination for cardiovascular populations in China: a scoping review.
    Vaccine. 2026;86:128761.
    >> Share

  33. LI W, Liu S, Cui W, Tang S, et al
    A novel ferritin-based nanoparticle vaccine targeting lgE confers protection against chronic allergic asthma in a murine model.
    Vaccine. 2026;86:128754.
    >> Share

  34. NDJEKA N, Subrayen P, Hanekom WA, Jassat W, et al
    Advancing national preparedness for the introduction of novel tuberculosis vaccines in South Africa: policy, evidence, and system readiness insights from a national workshop.
    Vaccine. 2026;86:128755.
    >> Share

  35. MELN I, Van Molle W, Velez MP, Baay M, et al
    Second regulatory workshop on utilising in silico models to expedite vaccine development, testing, and lifecycle management - an expert meeting report.
    Vaccine. 2026;86:128733.
    >> Share

  36. PERRY BRYCE NV, Marrero Arocho ML, Seybold D, Calhoun B, et al
    Improving Tdap vaccine uptake during pregnancy: a five-year analysis at a regional center.
    Vaccine. 2026 May 23:128709. doi: 10.1016/j.vaccine.2026.128709.
    >> Share

  37. OKUBO Y, Honjyo R, Uda K, Miyairi I, et al
    Nationwide survey for household preparedness and vaccination acceptance during a novel influenza pandemic scenario in Japan, 2025.
    Vaccine. 2026;86:128738.
    >> Share

  38. MACLENNAN CA, Davis P, Gottlieb SL, Seib KL, et al
    Consultation report - gonococcal immunoassays and standards for vaccine development.
    Vaccine. 2026;86:128694.
    >> Share

  39. PAREKH K, Paton DJ, Browning C, Wilsden G, et al
    Preparing for exotic foot-and-mouth disease virus outbreaks in the European neighbourhood: cross-neutralisation of internationally available vaccines against South American serotype O and serotype A field isolates.
    Vaccine. 2026;86:128718.
    >> Share

  40. GIANNINI F, Hogan AB, Blyth CC, Glass K, et al
    Modelling the impact of long-acting monoclonal antibody, maternal vaccine and hybrid programs of RSV immunisation in temperate Western Australia.
    Vaccine. 2026;86:128731.
    >> Share

  41. ROCUSKIE-MARKER CM, Huckaby AB, Conaway OM, Pyles GM, et al
    Evaluation of EcoCRM, virus-like particles, and mRNA as vaccine platforms against Borrelia burgdorferi.
    Vaccine. 2026;86:128696.
    >> Share

  42. CHAWANPAIBOON S, Anuwutnavin S, Kanjanapongporn A, Pooliam J, et al
    Corrigendum to "Breastfeeding women's attitudes towards and acceptance and rejection of COVID-19 vaccination: Implementation research" [Vaccine 41 (2023) 1198-1208].
    Vaccine. 2026;86:128752.
    >> Share

  43. FAIJUE DD, Bouaddi O, Segui AO, Morias B, et al
    Catch-up and life-course vaccination policies for adult and adolescent migrants in low-and-middle income countries: A policy analysis.
    Vaccine. 2026;85:128645.
    >> Share

  44. MATHEBULA L, Wiysonge CS, Zunza M
    Childhood vaccination uptake and associated determinants among caregivers of young children in Cape Town, South Africa.
    Vaccine. 2026;86:128730.
    >> Share

  45. COUNOUPAS C, Nisa A, Baker L, Pinto R, et al
    Targeted delivery of the BCG vaccine to dendritic cells improves protective efficacy against Mycobacterium tuberculosis.
    Vaccine. 2026;86:128753.
    >> Share

  46. KATANA EB, Kiiza D, Odongpiny EAL, Simbwa BN, et al
    Willingness to receive Ebola vaccines among pregnant and lactating women in Kampala, Uganda: insights from a post-outbreak cross-sectional study.
    Vaccine. 2026;86:128737.
    >> Share


    Virology

  47. ZIMINA A, Viktorova EG, Kouiavskaia D, Chumakov K, et al
    Towards the development of a mucosal vectored vaccine against enterovirus D68.
    Virology. 2026;621:110960.
    >> Share

  48. MEIRHAEGHE MR, Balfour HH Jr
    The rationale for universal use of a prophylactic Epstein-Barr virus vaccine.
    Virology. 2026;622:110970.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016